
Carol M. Koslow
Examiner (ID: 12920, Phone: (571)272-1371 , Office: P/1734 )
| Most Active Art Unit | 1734 |
| Art Unit(s) | 1734, 1754, 1793, 1755, 1108 |
| Total Applications | 5011 |
| Issued Applications | 4022 |
| Pending Applications | 258 |
| Abandoned Applications | 784 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10580947
[patent_doc_number] => 09303066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-05
[patent_title] => 'Treatments for gastrointestinal disorders'
[patent_app_type] => utility
[patent_app_number] => 14/116891
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19223
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116891
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116891 | Treatments for gastrointestinal disorders | May 10, 2012 | Issued |
Array
(
[id] => 9268797
[patent_doc_number] => 20140023714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'HEMOSTATIC COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/007798
[patent_app_country] => US
[patent_app_date] => 2012-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10945
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007798
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/007798 | Hemostatic compositions | Apr 25, 2012 | Issued |
Array
(
[id] => 10202616
[patent_doc_number] => 20150087604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'ANTI-FATTY ACID SYNTHASE POLYPEPTIDE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/112948
[patent_app_country] => US
[patent_app_date] => 2012-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13114
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112948
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112948 | ANTI-FATTY ACID SYNTHASE POLYPEPTIDE AND USE THEREOF | Apr 15, 2012 | Abandoned |
Array
(
[id] => 8453747
[patent_doc_number] => 20120264694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'COMPOSITION COMPRISING TORASEMIDE'
[patent_app_type] => utility
[patent_app_number] => 13/445380
[patent_app_country] => US
[patent_app_date] => 2012-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1503
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13445380
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/445380 | COMPOSITION COMPRISING TORASEMIDE | Apr 11, 2012 | Abandoned |
Array
(
[id] => 9518836
[patent_doc_number] => 20140155329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'Long-Acting Peptide Analogs'
[patent_app_type] => utility
[patent_app_number] => 14/110098
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6341
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110098
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110098 | Long-acting peptide analogs | Apr 4, 2012 | Issued |
Array
(
[id] => 8442305
[patent_doc_number] => 20120258921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'PEPTIDES FOR THE TREATMENT OF HEARING'
[patent_app_type] => utility
[patent_app_number] => 13/440591
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 50242
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13440591
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/440591 | Peptides for the treatment of hearing | Apr 4, 2012 | Issued |
Array
(
[id] => 11547275
[patent_doc_number] => 09616097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-11
[patent_title] => 'Formulations of guanylate cyclase C agonists and methods of use'
[patent_app_type] => utility
[patent_app_number] => 13/421769
[patent_app_country] => US
[patent_app_date] => 2012-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 54147
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13421769
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/421769 | Formulations of guanylate cyclase C agonists and methods of use | Mar 14, 2012 | Issued |
Array
(
[id] => 8683849
[patent_doc_number] => 20130052132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'Method for Producing Radioactively Labeled Polypeptide'
[patent_app_type] => utility
[patent_app_number] => 13/369903
[patent_app_country] => US
[patent_app_date] => 2012-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17757
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13369903
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/369903 | Method for Producing Radioactively Labeled Polypeptide | Feb 8, 2012 | Abandoned |
Array
(
[id] => 8928442
[patent_doc_number] => 20130184202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'Peptide Inhibitors and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/368833
[patent_app_country] => US
[patent_app_date] => 2012-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 8906
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13368833
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/368833 | Peptide Inhibitors and Methods of Use Thereof | Feb 7, 2012 | Abandoned |
Array
(
[id] => 8347355
[patent_doc_number] => 20120208266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'ENZYME CLEAVABLE CELL RELEASE POLYMERIC SURFACE'
[patent_app_type] => utility
[patent_app_number] => 13/367661
[patent_app_country] => US
[patent_app_date] => 2012-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16014
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13367661
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/367661 | ENZYME CLEAVABLE CELL RELEASE POLYMERIC SURFACE | Feb 6, 2012 | Abandoned |
Array
(
[id] => 8324652
[patent_doc_number] => 20120197059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'UBIQUITIN INTERACTING MOTIF PEPTIDES AS CANCER THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 13/362702
[patent_app_country] => US
[patent_app_date] => 2012-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 18527
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13362702
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/362702 | UBIQUITIN INTERACTING MOTIF PEPTIDES AS CANCER THERAPEUTICS | Jan 30, 2012 | Abandoned |
Array
(
[id] => 9338389
[patent_doc_number] => 20140065172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'DELIVERY SYSTEM AND CONJUGATES FOR COMPOUND DELIVERY VIA NATURALLY OCCURRING INTRACELLULAR TRANSPORT ROUTES'
[patent_app_type] => utility
[patent_app_number] => 13/982105
[patent_app_country] => US
[patent_app_date] => 2012-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 272301
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982105
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/982105 | DELIVERY SYSTEM AND CONJUGATES FOR COMPOUND DELIVERY VIA NATURALLY OCCURRING INTRACELLULAR TRANSPORT ROUTES | Jan 25, 2012 | Abandoned |
Array
(
[id] => 8612860
[patent_doc_number] => 20130018172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'Metal Abstraction Peptide and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/350247
[patent_app_country] => US
[patent_app_date] => 2012-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 20725
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13350247
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/350247 | Metal Abstraction Peptide and Uses Thereof | Jan 12, 2012 | Abandoned |
Array
(
[id] => 10121454
[patent_doc_number] => 09155800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-13
[patent_title] => 'Antimicrobial fusion compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/978224
[patent_app_country] => US
[patent_app_date] => 2012-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 24387
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978224
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/978224 | Antimicrobial fusion compounds and uses thereof | Jan 8, 2012 | Issued |
Array
(
[id] => 9134296
[patent_doc_number] => 20130295010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'HER2 BINDING PEPTIDES LABELLED WITH A 18F - CONTAINING ORGANOSILICON COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/996142
[patent_app_country] => US
[patent_app_date] => 2011-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 21277
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996142
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/996142 | HER2 BINDING PEPTIDES LABELLED WITH A 18F - CONTAINING ORGANOSILICON COMPOUND | Dec 18, 2011 | Abandoned |
Array
(
[id] => 9212565
[patent_doc_number] => 20140011742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'Bioactive Peptides and Proteins Containing Bioactive Peptides, their Uses and Processes for Making the Same'
[patent_app_type] => utility
[patent_app_number] => 13/992685
[patent_app_country] => US
[patent_app_date] => 2011-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10132
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992685
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/992685 | Bioactive Peptides and Proteins Containing Bioactive Peptides, their Uses and Processes for Making the Same | Dec 7, 2011 | Abandoned |
Array
(
[id] => 9094862
[patent_doc_number] => 20130274173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'STABLE HELICAL IONIC POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/990739
[patent_app_country] => US
[patent_app_date] => 2011-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 88
[patent_figures_cnt] => 88
[patent_no_of_words] => 52986
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990739
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/990739 | Stable helical ionic polypeptides | Nov 29, 2011 | Issued |
Array
(
[id] => 8453735
[patent_doc_number] => 20120264681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'BUFFERED OPHTHALMIC COMPOSITIONS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/291553
[patent_app_country] => US
[patent_app_date] => 2011-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 14877
[patent_no_of_claims] => 134
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13291553
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/291553 | BUFFERED OPHTHALMIC COMPOSITIONS AND METHODS OF USE THEREOF | Nov 7, 2011 | Abandoned |
Array
(
[id] => 9686452
[patent_doc_number] => 20140243217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'METHODS AND COMPOSITIONS FOR DETECTING PLANT EXPOSURE TO PLANT PATHOGENS'
[patent_app_type] => utility
[patent_app_number] => 13/817598
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16903
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817598
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/817598 | METHODS AND COMPOSITIONS FOR DETECTING PLANT EXPOSURE TO PLANT PATHOGENS | Nov 3, 2011 | Abandoned |
Array
(
[id] => 8483768
[patent_doc_number] => 20120283175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'ANTIBACTERIAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/289212
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18694
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13289212
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/289212 | ANTIBACTERIAL COMPOSITIONS | Nov 3, 2011 | Abandoned |